| III-31 Hannah Britz Physiologically-based pharmacokinetic (PBPK) modeling of the strong CYP1A2 inhibitor fluvoxamine Thursday 09:55-11:30 |
| III-31 Hannah Britz Physiologically-based pharmacokinetic (PBPK) modeling of the strong CYP1A2 inhibitor fluvoxamine Thursday 09:55-11:30 |